Noveris Health Sciences is trading at CA$0.06, down -7.69%, with no confirmed catalyst identified in available coverage.

  • No company-specific announcement dated October 19 or October 16 was found; the latest listed company release is from September 9.
  • Broader markets and the supplied biotech-sector context were positive, so neither clearly explains the decline.
  • Available external trading data was not used to override the supplied live price context.